|
1
|
Burger PC, Heinz ER, Shibata T and
Kleihues P: Topographic anatomy and CT correlations in the
untreated glioblastoma multiforme. J Neurosurg. 68:698–704. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller CR and Perry A: Glioblastoma. Arch
Pathol Lab Med. 131:397–406. 2007.PubMed/NCBI
|
|
3
|
Kilic T, Alberta JA, Zdunek PR, Acar M,
Iannarelli P, O’Reilly T, Buchdunger E, Black PM and Stiles CD:
Intracranial inhibition of platelet-derived growth factor-mediated
glioblastoma cell growth by an orally active kinase inhibitor of
the 2-phenylami-nopyrimidine class. Cancer Res. 60:5143–5150.
2000.PubMed/NCBI
|
|
4
|
Mukhtar H and Ahmad N: Tea polyphenols:
prevention of cancer and optimizing health. Am J Clin Nutr.
71:1698S–1702S. 2000.PubMed/NCBI
|
|
5
|
Fresco P, Borges F, Diniz C and Marques
MP: New insights on the anticancer properties of dietary
polyphenols. Med Res Rev. 26:747–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong AN, Yu R, Hebbar V, Chen C, Owuor E,
Hu R, Ee R and Mandlekar S: Signal transduction events elicited by
cancer prevention compounds. Mutat Res. 480–481:231–241. 2001.
View Article : Google Scholar
|
|
8
|
Ji BC, Hsu WH, Yang JS, Hsia TC, Lu CC,
Chiang JH, Yang JL, Lin CH, Lin JJ, Suen LJ, Gibson Wood W and
Chung JG: Gallic acid induces apoptosis via caspase-3 and
mitochondrion-dependent pathways in vitro and suppresses lung
xenograft tumor growth in vivo. J Agric Food Chem. 57:7596–7604.
2009. View Article : Google Scholar
|
|
9
|
Liu Z, Li D, Yu L and Niu F: Gallic acid
as a cancer-selective agent induces apoptosis in pancreatic cancer
cells. Chemotherapy. 58:185–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Curti V, Capelli E, Boschi F, Nabavi SF,
Bongiorno AI, Habtemariam S, Nabavi SM and Daglia M: Modulation of
human miR-17-3p expression by methyl 3-O-methyl gallate as
explanation of its in vivo protective activities. Mol Nutr Food
Res. 58:1776–1784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
14
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M
and Baba H: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weiss FU, Marques IJ and Woltering JM:
Retinoic acid receptor antagonists inhibit miR-10a expression and
block metastatic behavior of pancreatic cancer. Gastroenterology.
137:2136–2145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai
Y, Katakowski M, Chopp M and To SS: Gallic acid suppress cell
viability, proliferation, invasion and angiogenesis in human glioma
cells. Eur J Pharmacol. 641:102–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SH, Kim JK, Kim DW, Hwang HS, Eum WS,
Park J, Han KH, Oh JS and Choi SY: Antitumor activity of methyl
gallate by inhibition of focal adhesion formation and Akt
phosphorylation in glioma cells. Biochim Biophys Acta.
1830.4017–4029. 2013.
|
|
19
|
Sakagami H and Satoh K: Prooxidant action
of two antioxidants: ascorbic acid and gallic acid. Anticancer Res.
17:221–224. 1997.PubMed/NCBI
|
|
20
|
Strlic M, Radovic T, Kolar J and Pihlar B:
Anti- and prooxidative properties of gallic acid in fenton-type
systems. J Agric Food Chem. 50:6313–6317. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK,
Hsieh YC, Chen CC and Yuan SS: Gallic acid, a major component of
Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer
activity in human prostate cancer cells. Cancer Lett. 286:161–171.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Savi LA, Leal PC, Vieira TO, Rosso R,
Nunes RJ, Yunes RA, Creczynski-Pasa TB, Barardi CR and Simões CM:
Evaluation of anti-herpetic and antioxidant activities, and
cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic
acid. Arzneimittelforschung. 55:66–75. 2005.PubMed/NCBI
|
|
23
|
Kroes BH, van den Berg AJ, Quarles van
Ufford HC, van Dijk H and Labadie RP: Anti-inflammatory activity of
gallic acid. Planta Med. 58:499–504. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gichner T, Pospísil F, Velemínský J,
Volkeová V and Volke J: Two types of antimutagenic effects of
gallic and tannic acids towards N-nitroso-compounds-induced
mutagenicity in the Ames Salmonella assay. Folia Microbiol.
32:55–62. 1987. View Article : Google Scholar
|
|
25
|
Mirvish SS, Cardesa A, Wallcave L and
Shubik P: Induction of mouse lung adenomas by amines or ureas plus
nitrite and by N-nitroso compounds: effect of ascorbate, gallic
acid, thiocyanate and caffeine. J Natl Cancer Inst. 55:633–636.
1975.PubMed/NCBI
|
|
26
|
Inoue M, Suzuki R, Sakaguchi N, Li Z,
Takeda T, Ogihara Y, Jiang BY and Chen Y: Selective induction of
cell death in cancer cells by gallic acid. Biol Pharm Bull.
18:1526–1530. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fox JT, Sakamuru S, Huang R, Teneva N,
Simmons SO, Xia M, Tice RR, Austin CP and Myung K: High-throughput
geno-toxicity assay identifies antioxidants as inducers of DNA
damage response and cell death. Proc Natl Acad Sci USA.
109:5423–5428. 2012. View Article : Google Scholar
|
|
28
|
Zhang X, Ladd A, Dragoescu E, Budd WT,
Ware JL and Zehner ZE: MicroRNA-17-3p is a prostate tumor
suppressor in vitro and in vivo, and is decreased in high grade
prostate tumors analyzed by laser capture microdissection. Clin Exp
Metastasis. 26:965–979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Y, Fang F, Zhang J, Josson S, St Clair
WH and St Clair DK: miR-17* suppresses tumorigenicity of prostate
cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One.
5:e143562010. View Article : Google Scholar
|
|
30
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu H, Du L, Nagabayashi G, Seeger RC and
Gatti RA: ATM is down-regulated by N-Myc-regulated microRNA-421.
Proc Natl Acad Sci USA. 107:1506–1511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mansour WY, Bogdanova NV, Kasten-Pisula U,
Rieckmann T, Köcher S, Borgmann K, Baumann M, Krause M, Petersen C,
Hu H, Gatti RA, Dikomey E, Dörk T and Dahm-Daphi J: Aberrant
overexpression of miR-421 downregulates ATM and leads to a
pronounced DSB repair defect and clinical hypersensitivity in SKX
squamous cell carcinoma. Radiother Oncol. 106:147–154. 2013.
View Article : Google Scholar
|
|
33
|
Hao J, Zhang S, Zhou Y, Liu C, Hu X and
Shao C: MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer.
Biochem Biophys Res Commun. 406:552–557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
35
|
Gao Y, Luo LH, Li S and Yang C: miR-17
inhibitor suppressed osteosarcoma tumor growth and metastasis via
increasing PTEN expression. Biochem Biophys Res Commun.
444:230–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schee K, Lorenz S and Worren MM: Deep
sequencing the MicroRNA transcriptome in colorectal cancer. PLoS
One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar
|
|
38
|
Sanchez-Diaz PC, Hsiao TH, Chang JC, Yue
D, Tan MC, Chen HI, Tomlinson GE, Huang Y, Chen Y and Hung JY:
De-regulated microRNAs in pediatric cancer stem cells target
pathways involved in cell proliferation, cell cycle and
development. PLoS One. 8:e616222013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gowrishankar B, Ibragimova I, Zhou Y,
Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG and Cairns P:
MicroRNA expression signatures of stage, grade, and progression in
clear cell RCC. Cancer Biol Ther. 15:329–341. 2014. View Article : Google Scholar :
|
|
40
|
Manach C, Williamson G, Morand C, Scalbert
A and Rémésy C: Bioavailability and bioefficacy of polyphenols in
humans. I. Review of 97 bioavailability studies. Am J Clin Nutr.
81:230S–242S. 2005.PubMed/NCBI
|
|
41
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001.PubMed/NCBI
|
